{"slideshow_credits": null, "snippet": "The drug, used to treat kidney disease complications, can increase the risk of heart disease, bone density problems and death.", "abstract": "Food and Drug Administration gives drug maker Keryx Biopharmaceuticals approval in United States for its ferric citrate drug to treat kidney disease complications, but clearance requires unexpected safety warnings.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [], "organization": "THE ASSOCIATED PRESS", "original": "By THE ASSOCIATED PRESS", "contributor": ""}, "web_url": "http://www.nytimes.com/2014/09/06/business/warnings-issued-for-keryx-dialysis-drug.html", "lead_paragraph": "The drug, used to treat kidney disease complications, can increase the risk of heart disease, bone density problems and death.", "headline": {"main": "Warnings Issued for Keryx Dialysis Drug", "print_headline": "Warnings Issued for Keryx Dialysis Drug", "content_kicker": "Business Briefing "}, "_id": "540a5c8438f0d84fb8833892", "word_count": "148", "multimedia": [], "pub_date": "2014-09-06T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Keryx Biopharmaceuticals Inc", "name": "organizations", "is_major": "Y", "rank": "1"}, {"value": "Kidneys", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "3"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}